je.st
news
Tag: biopharma
Arca Biopharma Rating Reiterated by RBC Capital
2015-10-18 18:09:25| Biotech - Topix.net
's stock had its "sector perform" rating restated by stock analysts at RBC Capital in a research note issued to investors on Sunday, MarketBeat.com reports. They presently have a $7.00 price target on the biopharmaceutical company's stock, down from their prior price target of $8.00.
Array BioPharma says clinical trials combining its cancer-fighting drugs show encouraging results
2015-09-29 07:51:26| Biotech - Topix.net
Robyn Hamor, associate scientist, works on an enzyme linked immunosorbent assay at Array BioPharma in Boulder, Colorado.
Tags: show
results
clinical
drugs
RedHill Biopharma - 9 Late Stage Clinical Assets, $150 Million Market Cap - Is It Undervalued?
2015-09-11 14:41:16| Biotech - Topix.net
Every market day, we select up to 20 of our authors' top long and short ideas, exclusively for PRO subscribers. RedHill focuses on late stage oral gastrointestinal drugs; the company has two potential blockbusters in Phase 3 studies, 9 active clinical programs in total.
Arca Biopharma Upgraded to "Buy" by Zacks
2015-09-06 11:55:06| Biotech - Topix.net
The firm currently has a $1.25 target price on the biopharmaceutical company's stock. Zacks 's price target would suggest a potential downside of 80.47% from the stock's previous close.
ARCA Biopharma To Present At The Rodman & Renshaw 17th Annual Global Investment Conference
2015-09-02 07:36:17| drugdiscoveryonline News Articles
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, recently announced that its Chief Operating Officer, Thomas A. Keuer, will present at the Rodman & Renshaw 17th Annual Global Investment Conference, taking place September 8-10, 2015 in New York City
Tags: present
global
annual
conference
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] next »